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Abstract 
The severity of the sickling phenomenon has been observed to be more at pre puberty, but at puberty, the level of 
crises becomes fairly stable. This has been attributed to the sex hormones that are responsible for development of 
the sexual characteristics in both male and female. This study was designed to establish the normal level of these 
hormones (estradiol, progesterone, testosterone and prolactin) in the serum of persons with sickle cell disease in 
a steady state and in the other haemoglobin genotypes (HbAA, HbAS) with respect to age and gender. This is 
with the aim to establish sex hormone ranges and if there is significant difference in the level of these hormones 
in homozygous SS subjects as a result of the sickling phenomenon in southern Nigeria. Enzyme linked 
immunosorbent Assay (ELISA) method was used to estimate the level of the hormones. From the result, the 
level of the hormones showed a significant difference (P<0.05) in the gender, the age groups and the HbSS 
Subjects. The level of the hormones studied also increased with age in the three human haemoglobin 
electrophoretic patterns. The hormones were decreased significantly in the serum of the HbSS subjects and there 
was no significant difference (P>0.05) in the values obtained for the control ( HbAA and HbAS) subjects.  The 
findings indicated gonadal hypofunction in the sickle cell patients but with varied deviations from the mean 
result. 
Keywords: Estradiol; Progesterone; Testosterone; Prolactin; Sex hormones; Sickle cell; Haemoglobin 
electrophoresis; genotypes. 
 
INTRODUCTION 
Sickle cell disease is the most common genetic disorder in persons of African Origin ( Huisman, 1981) and the 
disorder comprises a spectrum of syndromes that range from the almost completely benign trait or carrier state 
( The AS genotype) to the most severe syndrome, the sickle cell anaemia due to the homozygous presence of the 
β-haemoglobin (producing the HbSS genotype). Sickle cell anaemia, an inheritance of mutant haemoglobin 
genes from both parents is globally wide spread. According to World Health Organisation (WHO) report, (2006), 
about 5% of the world’s population carries genes responsible for haemoglobinopathies and each year about 
300,000 infants are born with major haemoglobin disorders. More than 200,000 cases of sickle cell anaemia are 
in Africa (WHO, 2006). In Nigeria, the most populous country in the sub-region with about 150 million 
inhabitants (Nigeria census, 2006), 24% of the population are carriers of the mutant gene and the prevalence of 
the sickle cell anaemia is about 20 per 1000 births. The public health implications of sickle cell anaemia are 
obvious as it causes either death or disability. Its impact on human beings may therefore be assessed against the 
background of infant and under five mortality. Although an increasing proportion of affected children now 
survive past five years of age, they have a chronic disease and are at risk of premature death (Platt et al., 1994). 
For reasons that are not clear, sickle cell disease is of very variable severity. The severity of the sickling 
phenomenon has been observed to be more at pre-puberty, but at puberty, the level of crises becomes fairly 
stable. This has been attributed to sex hormones that are responsible for development of sexual characteristics in 
both male and female (Orudugba, 2012). The female attains puberty earlier and better sickling stability than the 
male and this might be as a result of the female sex hormone, estrogen. Some experts have postulated that the 
sickle cell disease also delay puberty in comparison with persons of HbAA genotype (Olutunbosun, 1978; Zemel, 
et al., 2007; Kim, 2014). 
 The hormones are chemical substances which travel from a special tissue, where they are relieved into 
the blood stream to distant responsive cells where the hormone exerts their characteristic effects (El-Hasmi et al., 
1991; Schimike et al., 1995). The sex hormones are responsible for the development of sexual characteristics in 
men and women and have been established to play a lot of physiologic and metabolic roles in the body (Goldfien, 
1998) (Lee, 2005). 
Sex steroids, also known as gonad steroids are steroid hormones, which interact with vertebrate 
androgen or estrogen receptors. Natural sex steroids are made by the gonads (ovaries or testes), by adrenal 
glands or by conversion from other sex steroids in other tissues such as liver or fat (Daisely, 2006). Sex steroids 
play important roles inducing the body changes known as primary sex characteristics and secondary sex 
characteristics. This development is controlled by sex hormones after the Y-chromosome and/or the SRY gene 
determines development. In many contexts, the two main classes of sex steroids are androgens and estrogens of 
which the most important human examples are testosterone and estradiol respectively. Other contexts will 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.6, No.18, 2016 
 
31 
include progestagen as a third class of sex steroid, distinct from androgens and estrogens. The conventional view 
of prolactin, as argued in some quarters of its sex origin and multifunctional nature, is that its major target-organ 
is the mammary gland and stimulating mammary gland development and milk production and was included in 
this study as part of sex hormone workup. 
The significance of establishing sex hormones and prolactin ranges in sickle cell disease lies in the fact 
that sickle cell patients are sexually active and are also interested in living a normal sex life and getting pregnant. 
As medical advances improve survival, reduce disease –related morbidity and improve quality of life, 
reproductive issues will take higher priority in the sickle cell disease community (Kim, 2014). The issue of 
whether steroid contraceptives are appropriate for women with homozygous sickle cell disease remains 
unresolved. Historically, women with sickle cell disease have experienced difficult pregnancies, characterised by 
high rates of maternal mortality and morbidity and poor infant outcomes (Freie, 1983), therefore unresolved 
questions about steroidal contraceptives in women with sickle cell disease (Young, 2001), sickle cell men with 
erectile dysfunction (Dada and Nduka, 1980), include whether using them may promote blood clots (Briggs and 
Briggs, 1972).  
The aim of this study therefore was to establish the levels of these hormones (estradiol, progesterone, 
testosterone and prolactin) in the blood of subjects with sickle cell disease (HbSS) in a steady state, the carriers 
(the HbAS) and normal genotype (HbAA) with respect to age and gender groups. This is with a view to establish 
the normal ranges and if possible any dysfunction associated with sickle haemoglobin and was primarily aimed 
at a comparative study of the three human haemoglobin electrophoretic patterns. Reproductive issues in women 
and men with sickle cell disease include a wide range of complications that are relatively common, however data 
from well designed, large clinical studies are limited and many studies are quite old, but remain relevant because 
they describe clinical complications and problems that persist in the sickle cell disease populations today despite 
advances in medical therapy. 
 
MATERIALS/METHODS 
Study Area 
The study was carried out in the southern part of Nigeria states of Bayelsa , Rivers and Cross Rivers. Blood 
samples were collected from subjects and volunteers at the university Teaching Hospital, Okolobiri; Federal 
Medical center, Yenegoa; University Teaching Hospital, and the General Hospital, all in Porthatcourt, Rivers 
State, from Univerity of Calabar teaching hospital and from patients that were indentified after counselling and 
genotyping to determine their haemoglobin electrophoretic pattern at the sickle cell centres and clinics. The 
control samples were collected from consented members of the public that has the genotype group HbAA and 
HbAS from the same environment especially the university community.  
Study Population 
A total of eight hundred and forty (840) subjects were used for this study and were distributed into 3 age groups 
of 2 -7, 8 -14, and 15 – 40 years for both male and female. This comprised of 40 female HbSS subjects in each 
age bracket, and 43, 39, 38 male HbSS subjects in 2 -7, 8 -14 and 15 -40 age groups respectively. The study 
subjects also included 600 males and females of HbAS and HbAA genotypes, with 50 subjects in each age and 
gender group. The subjects group were gender and age matched and excluded from the study were subjects 
indentified with different endocrine dysfunction (Stephen et al., 2008). Institutional ethical approval was 
received from the various departments of the hospitals and centres for this study. This study lasted for a period of 
5 years and covered the age range of 2 to 40 years. 
Sample Collection and Preparation 
About 5.0ml of blood were collected from each subject using the standard venepuncture technique. The samples 
were discharged into a clot-activator tube and then centrifuged for 10 minutes at 3,000 rpm. The serum collected 
was stored frozen at -20 ͦC and analysis was done within 5days of collection. The subject’s age and gender were 
noted after collection with history of menstrual cycle for females above age 14 years. Samples for age group 
above 14 years were collected twice at both follicular and luteal phase (Day2 and 21). This was because the 
study did pick interest in the luteal phase of their cycle because of the elevated levels of estradiol and 
progesterone at this phase. The essence and details of the study were explained to the subjects and their guardian 
and informed consent was obtained from them after approval from the management of the hospitals. 
Method of Assay 
The genotypes of the subjects were confirmed using haemoglobin electrophoresis. The enzyme linked 
immunosorbent (ELISA) method was used for the hormones (Amballi et al., 2007). The ELISA test is used on 
the principle of solid phase enzyme linked immunosorbent assay, where the antibody to be measured is 
incubated with specific antigen coupled to a solid phase (Uotila et al., 1981; Peter et al., 2001).The product kit 
was acquired from Micro well laboratories USA. The components of the ELISA kit were specifically designed to 
analyse the various sex hormones; estradiol, progesterone, testosterone and prolactin. It applies to in-vitro 
quantitative determination of the hormone concentration in serum. 
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Sampling method 
To achieve this reference range establishment, a random sampling of the different haemoglobin genotype class 
from the population was used. This took into consideration the age and gender of the subjects, excluding those 
that have different endocrine dysfunctions as established. The apparently healthy subjects were selected for the 
study and with a method that has been established to give a precise range of results in hormonal assay (Amballi 
et al., 2007). 
Statistical Analysis 
The data are expressed as mean ± standard deviation and normal ranges. Correlation between the groups studied 
was tested using the regression analysis. The results obtained from this were subjected to statistical analysis 
using standard computerized analysis tool of ANOVA: two factors without replication and standard t-test: pair 
two samples for mean. 95% confidence level (P<0.05) were used and considered significant. 
Results 
The results of the study on the levels of sex hormones and prolactin in the serum of HbAA, HbAS and HbSS 
subjects as grouped are presented in the tables below: The differences in levels (age group, male and female) 
were statistically calculated and its significance shown in the tables: The result showed significant decrease (P 
<0.05) in the values obtained for homozygous SS subjects and without any significant difference (P >0.05) 
between the heterozygote AS and homozygous AA. 
TABLE 1:        Mean + S.D results and the normal range for serum female estradiol in the three human                    
                          haemoglobin electrophoretic patterns with respect to Age. 
Hb Genotype Age Groups(yrs) No. of 
subjects(n) 
Mean + S.D 
(pg/ml) 
Lower limit -
Upper limit 
P Value 
HbAA 
 
 
 
HbAS 
 
 
 
HbSS 
 
0 – 7 
8 – 14 
15 – 40 (Day2) 
 
0 – 7 
8 – 14 
15 – 40 (Day2) 
 
0 – 7 
8 – 14 
15 – 40 (Day2) 
50 
50 
50 
 
50 
50 
50 
 
40 
40 
40 
14.64 +  7.50 
33.16 + 14.06 
48.95 +  20.61 
 
13.95 + 3.98 
28.36 +  13.59 
51.04 + 23.09 
 
6.88 + 2.17 
19.24 + 5.80 
38.65 +  15.10 
7.14 – 22.14 
19.10 – 47.22 
28.34 – 69.56 
 
9.97 – 17.93 
14.77 – 41.95 
27.95 – 74.13 
 
4.71 – 9.05 
13.44 – 25.04 
23 .55 – 53.75 
 
P > 0.05 
 
 
 
P > 0.05 
 
 
 
P < 0.05 
 
TABLE 2:        Mean + S.D results and the normal range for serum female estradiol in the three human                    
                        haemoglobin electrophoretic patterns with respect to Age (DAY 21) 
Hb Genotype Age Groups(yrs) No. of 
subjects(n) 
Mean + S.D 
(pg/ml) 
Lower limit -
Upper limit 
P Value 
HbAA 
 
HbAS 
 
HbSS 
15 – 40 
 
15 – 40 
 
15 - 40 
50 
 
50 
 
38 
73.95 +  25.61 
 
68.04 + 23.09 
 
48.63 + 15.10 
48.34 – 99.56 
 
44.95 – 91.13 
 
33.53 – 63.73 
P > 0.05 
 
P > 0.05 
 
P < 0.05 
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TABLE 3:      Mean + S.D results and the normal range for serum male estradiol in the three human                    
                        Haemoglobin electrophoretic patterns with respect to Age. 
Hb Genotype Age Groups(yrs) No. of 
subjects(n) 
Mean + S.D 
(pg/ml) 
Lower limit -
Upper limit 
P Value 
HbAA 
 
 
 
HbAS 
 
 
 
HbSS 
 
 
0 - 7 
8 - 14 
15 – 40 
 
0 – 7 
8 – 14 
15 – 40 
 
0 – 7 
8 – 14 
15 - 40 
50 
50 
50 
 
50 
50 
50 
 
43 
39 
38 
9.39 + 3.43 
13.13+ 8.80 
25.99 + 15.97 
 
8.36 + 4.68 
13.09 + 3.44 
24.43 + 11.56 
 
4.09 + 2.29 
9.02 + 2.64 
11.24 + 4.29 
5.96 – 12.82 
4.33 – 21.93 
10.02 – 41.96 
 
3.68 – 13.04 
9.65 – 16.53 
12.87 – 35.99 
 
1.80 – 6.38 
6.38 – 11.66 
6.95 – 15.53 
 
P > 0.05 
 
 
 
P > 0.05 
 
 
 
P < 0.05 
 
TABLE 4:        Mean + S.D results and the normal range for serum female progesterone in the three  
           Human haemoglobin electrophoretic patterns with respect to Age. 
Hb Genotype Age Groups(yrs) No. of 
subjects(n) 
Mean + S.D 
(ng/ml) 
Lower limit - 
Upper limit 
P Value 
HbAA 
 
 
 
HbAS 
 
 
 
HbSS 
0 – 7 
8 – 14 
15 – 40 (Day2) 
 
0 – 7 
8 – 14 
15 – 40 (Day2) 
 
0 – 7 
8 – 14 
15 – 40 (Day2) 
50 
50 
50 
 
50 
50 
50 
 
40 
40 
40 
 0.29 + 0.13 
0.61 + 0.10 
0.85 + 0.32 
 
0.23 + 0.09 
0.56 + 0.27 
0.79 + 0.35 
 
 0.16 + 0.09 
0.38 + 0.17 
 0.63 + 0.38 
0.16 – 0.42 
0.51 – 0.71 
0.53 – 1.17 
 
0.14 – 0.32. 
0.29 – 0.83 
0.44 – 1.14 
 
0.07 – 0.25 
0.21 – 0.55 
0.25 – 1.01 
 
P > 0.05 
 
 
 
P > 0.05 
 
 
 
P < 0.05 
 
TABLE 5:        Mean + S.D results and the normal range for serum female progesterone in the three        
           human haemoglobin electrophoretic patterns with respect to Age (DAY 21). 
Hb Genotype Age Groups(yrs) No. of 
subjects(n) 
Mean+ S.D 
(ng/ml) 
Lower limit - 
Upper limit 
P Value 
HbAA 
 
HbAS 
 
HbSS 
15 – 40 
 
15 – 40 
 
15 – 40  
50 
 
50 
 
38 
 
12.08 + 8.53 
 
10.95 + 7.28 
 
7.58 + 5.06 
3.55 – 20.61 
 
3.67 – 18.23 
 
2.52 – 12.64 
P > 0.05 
 
P > 0.05 
 
P < 0.05 
 
TABLE 6:        Mean + S.D results and the normal range for serum male progesterone in the three human                    
          haemoglobin electrophoretic patterns with respect to Age. 
Hb Genotype Age Groups(yrs) No of subjects(n) Mean+  S.D 
(ng/ml) 
Lower limit – 
Upper limit 
P Value 
HbAA 
 
 
 
HbAS 
 
 
 
HbSS 
0 – 7 
8 – 14 
15 – 40  
 
0 – 7 
8 – 14 
15 – 40 
 
0 – 7  
8 – 14 
15 – 40  
50 
50 
50 
 
50 
50 
50 
 
43 
39 
38 
0.23 + 0.09 
0.33 + 0.14 
0.85 + 0.32 
 
0.18 +0.05 
0.27 + 0.10 
0.49 + 0.25 
 
 0.09 + 0.06 
0.20 + 0.10 
 0.32 +  0.11 
0.14 – 0.32 
0.19 – 0.47 
0.53 – 1.17 
 
0.13 – 0.23 
0.17 – 0.37 
0.24 – 0.74 
 
0.03 – 0.15 
0.10 – 0.30 
0.21 – 0.43 
 
P > 0.05 
 
 
 
P > 0.05 
 
 
 
P < 0.05 
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TABLE 7:      Mean + S.D results and the normal range for serum male testosterone in the three human                    
          haemoglobin electrophoretic patterns with respect to Age. 
Hb Genotype Age Groups(yrs) No of subjects(n) Mean + S.D 
(ng/ml) 
Lower limit – 
Upper limit 
P Value 
HbAA 
 
 
 
HbAS 
 
 
 
HbSS 
 
0 – 7 
8 – 14  
15 – 40  
 
0 – 7 
8 – 14  
15 – 40  
 
0 – 7 
8 – 14  
15 – 40 
50 
50 
50 
 
50 
50 
50 
 
43 
39 
38 
0.12 + 0.09 
 0.62 + 0.48  
8.70 + 5.82  
 
0.11 + 0.04 
0.52 + 0.42 
8.24 + 5.13 
 
0.06 + 0.04 
0.29 +0.13 
4.73 + 2.56 
0.03 – 0.21 
0.14 – 1.10 
2.88 – 14.52 
 
0.07 – 0.15 
0.10 – 0.94 
3.11 – 13.37 
 
0.02 – 0.1 
0.16 – 0.42 
2.17 – 7.29 
 
P > 0.05 
 
 
 
P > 0.05 
 
 
 
P < 0.05 
 
TABLE 8:        Mean + S.D results and the normal range for serum female testosterone in the three   
                         human haemoglobin electrophoretic patterns with respect to Age. 
Hb Genotype Age Groups(yrs) No of subjects(n) Mean + S.D 
(ng/ml) 
Lower limit – 
Upper limit 
P Value 
HbAA 
 
 
 
HbAS 
 
 
 
HbSS 
 
0 – 7 
8 – 14  
15 – 40  
 
0 – 7 
8 – 14  
15 – 40  
 
0 – 7 
8 – 14  
15 – 40 
50 
50 
50 
 
50 
50 
50 
 
40 
40 
40 
0.08 + 0.02 
 0.18 + 0.03  
0.65 + 0.14  
 
0.07 + 0.03 
0.12 + 0.06 
0.55 + 0.18 
 
0.05 + 0.03 
0.08 +0.03 
0.41 + 0.13 
0.06 – 0.10 
0.15 – 0.21 
0.51 – 0.79 
 
0.04 – 0.10 
0.06 – 0.18 
0.37 – 0.73 
 
0.02 – 0.08 
0.05 – 0.11 
0.28 – 0.54 
 
P > 0.05 
 
 
 
P > 0.05 
 
 
 
P < 0.05 
 
TABLE 9:      Mean + S.D results and the normal range for serum male prolactin in the three human                    
                        haemoglobin electrophoretic patterns with respect to Age. 
 
Hb Genotype Age Groups(yrs) No of subjects(n) Mean + S.D 
(ng/ml) 
Lower limit – 
Upper limit 
P Value 
HbAA 
 
 
 
HbAS 
 
 
 
HbSS 
 
0 – 7 
8 – 14  
15 – 40  
 
0 – 7 
8 – 14  
15 – 40  
 
0 – 7 
8 – 14  
15 – 40  
50 
50 
50 
 
50 
50 
50 
 
43 
39 
38 
2.69 + 0.57 
 4.93 + 1.55  
10.82 + 4.52  
 
2.47 + 0.79 
3.97 + 0.62 
8.34 + 3.05 
 
1.67 + 0.96 
2.58 +1.20 
4.15 + 1.63 
2.12 – 3.26 
3.38 – 6.48 
6.30 – 15.34 
 
1.68 – 3.28 
 3.35– 4.59 
5.29 – 13.39 
 
0.71 – 2.63 
1.38 – 3.78 
2.52 – 5.78 
 
P > 0.05 
 
 
 
P > 0.05 
 
 
 
P < 0.05 
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TABLE 10:        Mean + S.D results and the normal range for serum female prolactin in the three human                    
                          haemoglobin electrophoretic patterns with respect to Age. 
Hb Genotype Age Groups(yrs) No of subjects(n) Mean + S.D 
(ng/ml) 
Lower limit – Upper 
limit 
P Value 
HbAA 
 
 
 
HbAS 
 
 
 
HbSS 
 
0 – 7 
8 – 14  
15 – 40  
 
0 – 7 
8 – 14  
15 – 40  
 
0 – 7 
8 – 14  
15 – 40  
50 
50 
50 
 
50 
50 
50 
 
40 
40 
40 
3.40 + 1.82 
 8.80 + 3.89  
12.43 + 3.66  
 
3.22 + 1.75 
6.48 + 3.59 
11.60 + 4.48 
 
2.39 + 1.55 
5.16 +1.29 
7.65 + 2.51 
1.58 – 5.22 
4.91 – 12.69 
8.77 – 16.09 
 
1.47 – 4.97 
2.89 – 10.07 
7.12 – 16.08 
 
0.84 – 3.94 
3.87 – 6.45 
5.14 – 10.16 
 
P > 0.05 
 
 
 
P > 0.05 
 
 
 
P < 0.05 
 
Discussion 
The age of puberty and menarche is known to be generally delayed in African Sickle Cell Patients (Olatunbosun, 
1978; Konotey-Ahuhu, 1981). Sex hormones are responsible for some of the most dramatic changes that occur in 
the body. They control puberty, egg and sperm production, pregnancy, birth and lactation (Kim, 2014). The 
findings from the measurement of the sex hormones (estradiol, progesterone, testosterone and prolactin) in some 
sickle cell subjects in southern Nigeria made some revelations. Analyses of the findings as illustrated in the 
result section (table 1 – 10), showed that the serum level of the hormones increased with age and differ 
significantly with respect to age and gender. The findings also showed that there was a significant decrease in the 
production of these hormones in sickle cell disease when the subjects are gender and age matched. The 
differences in levels obtained were significant for both male and female and different age groups. The result is in 
agreement with the previous findings (Olatunji and Frasier, 1975; Abudu et al, 2011). Comparative studies have 
shown that in all human haemoglobin genotype classes studied (HbAA, HBAS, HBSS) variables existed in the 
order HbAA>HbAS>HbSS subjects. Statistical analysis showed the differences that existed in the HbAA and 
HbAS subjects for these hormone levels were not significant (P>0.05). But significant differences (P<0.05) 
existed between the levels in HbAA and HbSS and the levels in HbAS and HbSS subjects. The differences 
exhibited by the levels in the hormones are more pronounced after puberty (see result section), with the normal 
ranges as shown in tables 1 -10.  
Gonadal malfunction can be genetic, as the function of the testes and the ovaries were determined by 
the integrity of the hypothalamic pituitary-gonadal axis. Certain genetic disease might affect the gonadal 
function that might have various clinical manifestations of the hormone effects (Abbasi et al., 1976; Andrea, 
2005; Taddesse et al., 2012). Prepubertal development decreases sex hormones binding globulin (SHBG) 
(Asterios and Feudon, 2005). Sex hormones and other physiologic differences between male and females 
therefore will alter the expressivity of a gene (Andrea, 2005). After birth, sexual development does not occur 
until puberty. Infertility is known complication in males and females with sickle cell disease. This has been 
attributed to relative primary gonadal failure, impotence and priapism or delayed or impaired sexual 
development (Olatunji and Frasier, 1975). Low level of the sex hormones and prolactin may be a reflection of 
hypogonadism secondary to hypopituitarism (Davies and Brosovick, 1989) (Abbasi et al., 1976) (Dada and 
Nduka, 1980). 
The result suggested that the sickle cell gene abnormality might have an adverse effect on the endocrine 
functions. 
 
Conclusion 
The findings from the study indicated that the hormones were low in serum of HbSS subjects and there was no 
significant difference in the values obtained for HbAS with respect to HbAA subjects. There was a significant 
difference in the values obtained for male, females and the age groups. The low level of the sex hormones and 
prolactin has been attributed to gonadal hypofunction in the sickle cell subjects. In reproductive endocrinology, 
reference hormonal values are needed, especially in the clinical evaluations of cases of infertility in both male 
and females. This study will help in sorting out various approaches to health maintenance and complications of 
patients with sickle cell disease, particularly in the prescription of steroids in the management of crises and 
infertility in female patients with sickle cell anaemia that have not been really compared to healthy subjects in 
southern Nigeria and therefore forms the basis for comparison for health professional practice. 
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